CRLVSSXTC• 3 Months (Normalized)
CRL vs SXTC (Charles River Laboratories International Inc. vs China SXT Pharmaceuticals Inc.)
Showing Closing Date Range from Jul 7 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CRL Performance $290.19
+26.9%
Charles River Laboratories International Inc.
Normalized Baseline0.00%
SXTC Performance $2.41
-98.78%
China SXT Pharmaceuticals Inc.
Normalized Baseline0.00%
Alpha Spread Margin CRL LEADS
+125.68 pts
CRL outperforming by 125.68 percentage points
CRLSXTC
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CRL SXTC
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | CRL Price | CRL Gain (%) | SXTC Price | SXTC Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $290.19 | +26.90% | $2.41 | -98.78% | +125.68% |
| Oct 01, 2026 | $286.83 | +25.43% | $2.96 | -98.50% | +123.93% |
| Sep 30, 2026 | $295.01 | +29.01% | $3.01 | -98.47% | +127.48% |
| Sep 29, 2026 | $295.96 | +29.42% | $2.81 | -98.57% | +127.99% |
| Sep 28, 2026 | $294.59 | +28.82% | $2.52 | -98.72% | +127.54% |
| Sep 25, 2026 | $292.84 | +28.06% | $- | - | |
| Sep 23, 2026 | $277.33 | +21.27% | $2.51 | -98.72% | +119.99% |
| Sep 22, 2026 | $285.11 | +24.68% | $- | - | |
| Sep 21, 2026 | $279.01 | +22.01% | $2.38 | -98.79% | +120.80% |
| Sep 18, 2026 | $278.06 | +21.59% | $2.40 | -98.78% | +120.37% |
| Sep 17, 2026 | $281.67 | +23.17% | $2.44 | -98.76% | +121.93% |
| Sep 16, 2026 | $273.41 | +19.56% | $2.19 | -98.89% | +118.45% |
| Sep 15, 2026 | $272.88 | +19.33% | $2.36 | -98.80% | +118.13% |
| Sep 14, 2026 | $273.11 | +19.43% | $2.66 | -98.65% | +118.08% |
| Sep 11, 2026 | $278.26 | +21.68% | $2.56 | -98.70% | +120.38% |
Page 1 of 5